Diuretics Flashcards
1
Q
Thiazide diuretics
Prototype
site of action
action
precaution
A
- Prototype: hydrochlorothiazide
- site of action: distal convoluted tubule
- action: impairs Na and Cl reabsorption
- precautions: K depleting
- because there is more Na in the tubule when it gets to the end, more K is excreted
2
Q
When are thiazides (Hctz) often used?
Anesthesia concerns?
A
- Antihypertensive
- Initially from decreased fluid volume
- sustained effect is caused by peripheral vasodilation
- Anesthesia concerns:
- hypokalemia
- hypochloremia
- hypomagnesemia
- muscle weakness potentiates muscle relaxants
- nephropathy
- increased risk of digoxin toxicity
- fluid volume status
3
Q
Furosimide
location of action
timing of effect
dose
PB
excretion
A
- Loop diuretic- blocks the Na/K/Cl channel
- Diuresis begins 2-10 minutes following IV injection
- dose: 0.1-1.0 mg/kg
- start with 5 mg in the OR
- Extensive protein binding
- Excreted by glomerular filtration and renal tubule secretion
4
Q
What is furosemide used for?
A
- Uses:
- mobilization of edema fluid
- peripheral vasodilation precedes onset of diuresis, but furosemide only decreased BP by loss of fluid
- reduction of ICP
- decrease venous return
- treat hypercalcemia
- they inhibit absorption of Ca++
- differential diagnosis of oliguria
- small dose of 0.1 mg/kg will stimulate diuresis in presence of excessive ADH
5
Q
What are the side effects of loop diuretics?
A
- hypokalemia, hypochloremia
- presynaptic inhibition of cAMP and subsequent release of ACh potentiates nondepolarizing muscle relaxants (d/t hypokalemia??)
-
enhances possibility of nephrotoxicity when administered with aminoglycosides and cephalosporins
- don’t mix if they already have nephrotoxicity
- decreased renal clearance of lithium
- possible cross reactivity of sulfonamide allergy
6
Q
What kind of diuretic is Mannitol?
Structure? function?
administration?
clearance?
A
- Mannitol is an osmotic diuretic
- 6 carbon sugar- Hexose
- Cleared from plasma through glomerular filtration, once in tubule fluid, it increases osmolarity and water, Na, Cl, and HCO3 is excreted
- Must give IV- it does not ever enter cells
- Clearance 100% by glomerular filtration, none of it is reabsorbed
7
Q
Uses of Mannitol
A
- Differential diagnosis of oliguria-
- uop will increase if the cause of low UOP is low intravascular fluid volume
- UOP will not increase if cause of the problem is glomerular or renal tubule function
- prophylaxis in acute renal failure
- easier to manage fluid status, but no evidence of renal protective effect
- it is seen to be effective after renal transplant
- reduction of ICP
- reduction of IOP
8
Q
What are the two ways mannitol can decrease ICP?
A
- increased plasma osmolarity draws water from tissues, including the brain
- decreases Cerebral spinal fluid by decreasing the rate of production of if
9
Q
What is the dose of mannitol?
onset, DOA
Anesthesia concerns?
A
- 0.25-1.00 g/kg IV
- usually dose on higher end unless patient had cardiac problems/wont be able to tolerate significant increase in intravascular fluid
- Exerts effect in 10-15 min and lasts 2 hours
- Anesthesia concerns:
- pulmonary edema
- hypovolemia
- electrolyte changes
10
Q
What are some potassium sparing diuretics?
A
- Epitheleal sodium channel blockers
- Triamterene
- Aldosterone antagonists
- spironolactone
11
Q
Triamterene:
site of action
action
precaution
A
- Site of action: collecting duct
- Action: Na channel blockade and inhibits K secretion into tubule; non-competative antagonism of aldosterone
- Precautions: can cause hyperkalemia
- Often used in combo with HCTZ
12
Q
Spironolactone
type of diuretic
structure
use
A
- Aldosterone antagonist (competitive); K sparing
- Structure: synthetic 17 lactone drug
- Use: primarily to treat heart failure, ascites, low-renin hypertension, hypokalemia, and Conn’s syndrome
- Spironolactone is a weak diuretic, and is usually combined with other diuretics; Not often used in the perioperative arena
13
Q
What is the Carbonic Anhydrase inhibitor?
use?
how does it work?
A
- Acetazolamide (Diamox)
- used to treat Gloucoma, altitude sickness, ICP
- Carbonic anhydrase catalyzes H+ and HCO3 released from CO2 and H2O. H+ is then excreted in exchange for Na on the renal luminal membrane and HCO3 is reabsorbed with Na
- because this enzyme is inhibited, excretion of H+ ions is diminished and loss of HCO3 is increased
- Cl- is retained by kidney to offset loss of HCO3
- Less H+ ions in distal tubules results in excretion of K in exchange for Na
14
Q
Dopaminergic agents
dose
Renal protection
A
- Low dose Dopamine 1-3 mcg/kg/min
- Renal protection
- vasodilation
- inhibition of Na-K-AtPase pump decreases renal O2 consumtion
- effect diminished after 48 hours d/t downregulation of dopaminergic receptors